EUVIMEDEUVIMED entdecken
Crossref

REMODELAMENTO VENTRICULAR E DESFECHOS CLÍNICOS APÓS TERAPIAS TRANSCATETER EM DOENÇAS VALVARES: REVISÃO SISTEMÁTICA E METANÁLISE

Felipe Matheus Sant’Anna Aragão, Iapunira Catarina Sant’Anna Aragão, João Lucas Silveira Guerra, Miguel Maximiano Morais Moreira, Enzo Gabriel Martins Aragão, Bárbara Costa Lourenço, Vera Lúcia Corrêa Feitosa, Francisco Prado Reis, José Aderval Aragão

Revista Científica Ipedss · 2026 · 06 (01)

DOI: 10.55703/27644006060122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Científica Ipedss, 2026. Verfasst von Felipe Matheus Sant’Anna Aragão und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Valvular heart diseases are an important cause of cardiovascular morbidity and mortality, especially among older populations and patients with multiple comorbidities. In recent decades, transcatheter therapies have profoundly changed the treatment of aortic stenosis, mitral regurgitation, and tricuspid regurgitation, expanding therapeutic options for patients at high surgical risk or with contraindications to conventional surgery. This systematic review with subgroup-structured meta-analysis aimed to evaluate the effects of transcatheter therapies for valvular heart diseases on left and right ventricular remodeling, as well as their association with clinical outcomes. Thirty studies involving TAVI/TAVR, mitral transcatheter edge-to-edge repair, transcatheter mitral valve replacement, and transcatheter tricuspid interventions were included. Due to the clinical and methodological heterogeneity among the valvular diseases, devices, and populations evaluated, the results were organized by therapeutic subgroups and analyzed through a tabular quantitative synthesis. The findings indicated that TAVI/TAVR presented the most consolidated evidence, being associated with reduced pressure overload, left ventricular reverse remodeling, and improved clinical outcomes across different risk profiles. In mitral therapies, the benefit was more dependent on patient selection, baseline ventricular remodeling, and the proportionality of mitral regurgitation. In tricuspid interventions, improvements in quality of life, reduction of regurgitation, and potential right-sided chamber remodeling were observed, although the effects on mortality still require further confirmation. In conclusion, ventricular remodeling is a relevant marker of therapeutic response and prognosis after transcatheter valve therapies and should be incorporated into clinical, echocardiographic, and methodological assessment in future studies. Keywords: heart valve diseases; transcatheter procedures; ventricular remodeling; meta-analysis.

Zitieren

APA

Aragão, F. M. S., Aragão, I. C. S., Guerra, J. L. S., Moreira, M. M. M., Aragão, E. G. M., Lourenço, B. C., Feitosa, V. L. C., Reis, F. P., & Aragão, J. A. (2026). REMODELAMENTO VENTRICULAR E DESFECHOS CLÍNICOS APÓS TERAPIAS TRANSCATETER EM DOENÇAS VALVARES: REVISÃO SISTEMÁTICA E METANÁLISE. Revista Científica Ipedss, 06(01). https://doi.org/10.55703/27644006060122

Vancouver

Aragão FMS, Aragão ICS, Guerra JLS, Moreira MMM, Aragão EGM, Lourenço BC, et al. REMODELAMENTO VENTRICULAR E DESFECHOS CLÍNICOS APÓS TERAPIAS TRANSCATETER EM DOENÇAS VALVARES: REVISÃO SISTEMÁTICA E METANÁLISE. Revista Científica Ipedss. 2026;06(01). doi:10.55703/27644006060122

BibTeX
@article{Arago2026,
  author = {Aragão, Felipe Matheus Sant’Anna and Aragão, Iapunira Catarina Sant’Anna and Guerra, João Lucas Silveira and Moreira, Miguel Maximiano Morais and Aragão, Enzo Gabriel Martins and Lourenço, Bárbara Costa and Feitosa, Vera Lúcia Corrêa and Reis, Francisco Prado and Aragão, José Aderval},
  title = {REMODELAMENTO VENTRICULAR E DESFECHOS CLÍNICOS APÓS TERAPIAS TRANSCATETER EM DOENÇAS VALVARES: REVISÃO SISTEMÁTICA E METANÁLISE},
  journal = {Revista Científica Ipedss},
  year = {2026},
  volume = {06},
  number = {01},
  doi = {10.55703/27644006060122}
}
Kostenlos starten →